1. Home
  2. CRL vs LUMN Comparison

CRL vs LUMN Comparison

Compare CRL & LUMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

N/A

Current Price

$168.36

Market Cap

8.3B

Sector

Health Care

ML Signal

N/A

Logo Lumen Technologies Inc.

LUMN

Lumen Technologies Inc.

N/A

Current Price

$6.72

Market Cap

8.6B

ML Signal

N/A

Company Overview

Basic Information
Metric
CRL
LUMN
Founded
1947
1968
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Commercial Physical & Biological Resarch
Telecommunications Equipment
Sector
Health Care
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
8.3B
8.6B
IPO Year
1999
1994

Fundamental Metrics

Financial Performance
Metric
CRL
LUMN
Price
$168.36
$6.72
Analyst Decision
Buy
Hold
Analyst Count
13
5
Target Price
$197.58
$7.25
AVG Volume (30 Days)
1.3M
11.1M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,857,601,000.00
$12,402,000,000.00
Revenue This Year
$2.11
N/A
Revenue Next Year
$2.95
N/A
P/E Ratio
N/A
N/A
Revenue Growth
10.48
N/A
52 Week Low
$91.86
$3.01
52 Week High
$228.88
$11.95

Technical Indicators

Market Signals
Indicator
CRL
LUMN
Relative Strength Index (RSI) 39.71 37.61
Support Level $166.86 $6.24
Resistance Level $182.81 $7.39
Average True Range (ATR) 7.69 0.40
MACD 1.71 -0.06
Stochastic Oscillator 54.40 17.66

Price Performance

Historical Comparison
CRL
LUMN

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

About LUMN Lumen Technologies Inc.

Lumen Technologies is one of the largest telecommunications carriers serving global enterprises. The merger with Level 3 in 2017, the 2022 divestiture of much of its local phone business in rural areas, and the 2026 sale of its remaining consumer fiber network to AT&T have shifted the company's operations away from the legacy consumer business and toward enterprises services, which account for about 90% of revenue. Lumen offers businesses a full suite of communications services, providing colocation and data center services, data transportation, phone service, and internet access.

Share on Social Networks: